Harmony Biosciences Holdings Inc (HRMY)
33.43
+0.39
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
33.00
-0.43
(-1.29%)
After-Hours: 20:00
Harmony Biosciences Holdings Total Assets (Quarterly): 928.14M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 928.14M |
| June 30, 2024 | 858.38M |
| March 31, 2024 | 846.98M |
| December 31, 2023 | 811.45M |
| September 30, 2023 | 777.77M |
| June 30, 2023 | 760.18M |
| March 31, 2023 | 715.09M |
| December 31, 2022 | 673.87M |
| September 30, 2022 | 643.46M |
| June 30, 2022 | 505.03M |
| Date | Value |
|---|---|
| March 31, 2022 | 464.00M |
| December 31, 2021 | 433.44M |
| September 30, 2021 | 391.09M |
| June 30, 2021 | 359.70M |
| March 31, 2021 | 337.25M |
| December 31, 2020 | 427.07M |
| September 30, 2020 | 320.07M |
| June 30, 2020 | 168.82M |
| March 31, 2020 | 163.09M |
| December 31, 2019 | 106.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
106.70M
Minimum
Dec 2019
928.14M
Maximum
Sep 2024
534.58M
Average
484.52M
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 37.44B |
| EyePoint Pharmaceuticals Inc | 324.25M |
| Cassava Sciences Inc | 243.57M |
| Capricor Therapeutics Inc | 38.28M |
| Anavex Life Sciences Corp | 141.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 331.33M |
| Shareholders Equity (Quarterly) | 596.80M |
| Debt to Equity Ratio | 0.3064 |
| Current Ratio | 3.239 |
| Net Debt Paydown Yield | 0.08% |